Source: Health Products and Food Branch (CA) Revision Year: 2022
Table 2. Dosage Forms, Strengths, Composition and Packaging:
| Route of Administration | Dosage Form/Strength/Composition | Non-medicinal Ingredients |
|---|---|---|
| Topical | Solution 1.5% w/w of diclofenac sodium | dimethyl sulfoxide, ethanol, glycerine and propylene glycol in purified water |
PENNSAID is a clear and odourless liquid, supplied in low-density polyethylene bottles of 15, 30 and 60 mL and high-density polyethylene bottles of 15, 30, 60 and 120 mL with a plastic dropper cap.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Paladin Labs Inc., 100 Alexis-Nihon Blvd., Suite 600, St-Laurent, Quebec, H4M 2P2 255809 |
Date of approval:
October 20, 2003 February 16, 2022 |
| Drug | Countries | |
|---|---|---|
| PENNSAID | Austria, Canada, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
